L. Cals
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 11
- Colorectal Cancer Treatments and Studies 8
- Global Cancer Incidence and Screening 3
-
- Lung Cancer Treatments and Mutations 7
- Advanced Breast Cancer Therapies 2
- Co-authors
- Xavier Pivot (19 shared papers)Jean‐Luc Raoul (5 shared papers)Jean‐Luc Van Laethem (5 shared papers)Catherine Brézault (5 shared papers)Marc Peeters (4 shared papers)Cristian Villanueva (6 shared papers)L. Chaigneau (9 shared papers)Fernando Bazán (9 shared papers)
In The Last Decade
L. Cals
40 papers receiving 658 citations
Peers
Comparison fields: 5 of 74
- Oncology 392
- Otorhinolaryngology 59
- Hepatology 60
- Pulmonary and Respiratory Medicine 168
- Cancer Research 79
Countries citing papers authored by L. Cals
This map shows the geographic impact of L. Cals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Cals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Cals more than expected).
Fields of papers citing papers by L. Cals
This network shows the impact of papers produced by L. Cals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Cals. The network helps show where L. Cals may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Cals, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 77 | |
| 2 | 2013 | 74 | |
| 3 | 2001 | 67 | |
| 4 | 2011 | 41 | |
| 5 | 2009 | 41 | |
| 6 | 2000 | 33 | |
| 7 | 2007 | 30 | |
| 8 | 2011 | 24 | |
| 9 | 2004 | 24 | |
| 10 | 2012 | 23 | |
| 11 | 2004 | 22 | |
| 12 | 1997 | 20 | |
| 13 | 2007 | 19 | |
| 14 | 2008 | 19 | |
| 15 | Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC) | 2005 | 17 |
| 16 | 2012 | 14 | |
| 17 | 2012 | 14 | |
| 18 | Recommandations pour la pratique clinique de Saint-Paul-de-Vence | 2005 | 11 |
| 19 | 2011 | 9 | |
| 20 | 2013 | 9 |
About L. Cals
L. Cals is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Otorhinolaryngology and Hematology, having authored 41 papers that have together received 677 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers), Head and Neck Cancer Studies (6 papers), Global Cancer Incidence and Screening (3 papers), BRCA gene mutations in cancer (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (392 citations), Otorhinolaryngology (59 citations), Hepatology (60 citations), Pulmonary and Respiratory Medicine (168 citations) and Cancer Research (79 citations). L. Cals has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Xavier Pivot, Jean‐Luc Raoul, Jean‐Luc Van Laethem, Catherine Brézault, Marc Peeters, Cristian Villanueva, L. Chaigneau, Fernando Bazán, Jean-Claude Vedovato and P. Rougier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, Critical Reviews in Oncology/Hematology and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.